These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 33401157)

  • 1. Acute toxicity and health-related quality of life after accelerated whole breast irradiation in 5 fractions with simultaneous integrated boost.
    Van Hulle H; Vakaet V; Monten C; Deseyne P; Schoepen M; Colman C; Paelinck L; Van Greveling A; Post G; Speleers B; Vandecasteele K; Mareel M; De Neve W; Veldeman L
    Breast; 2021 Feb; 55():105-111. PubMed ID: 33401157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial.
    Meattini I; Saieva C; Miccinesi G; Desideri I; Francolini G; Scotti V; Marrazzo L; Pallotta S; Meacci F; Muntoni C; Bendinelli B; Sanchez LJ; Bernini M; Orzalesi L; Nori J; Bianchi S; Livi L
    Eur J Cancer; 2017 May; 76():17-26. PubMed ID: 28262584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy.
    Versmessen H; Vinh-Hung V; Van Parijs H; Miedema G; Voordeckers M; Adriaenssens N; Storme G; De Ridder M
    BMC Cancer; 2012 Oct; 12():495. PubMed ID: 23098579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerated radiotherapy in patients over sixty years old after mastectomy: Acute and one-year physician-assessed toxicity and health-related quality of life.
    Vakaet V; Van Hulle H; Quataert V; Deseyne P; Schoepen M; Paelinck L; Post G; Van Greveling A; Speleers B; Mareel M; De Neve W; Monten C; Veldeman L
    Breast Dis; 2022; 41(1):261-266. PubMed ID: 35599462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life after breast-conserving therapy and adjuvant radiotherapy for non-low-risk ductal carcinoma in situ (BIG 3-07/TROG 07.01): 2-year results of a randomised, controlled, phase 3 trial.
    King MT; Link EK; Whelan TJ; Olivotto IA; Kunkler I; Westenberg AH; Gruber G; Schofield P; Chua BH;
    Lancet Oncol; 2020 May; 21(5):685-698. PubMed ID: 32203696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials.
    Hopwood P; Haviland JS; Sumo G; Mills J; Bliss JM; Yarnold JR;
    Lancet Oncol; 2010 Mar; 11(3):231-40. PubMed ID: 20138809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
    Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
    Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
    Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
    JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity modulated radiotherapy with simultaneous integrated boost vs. conventional radiotherapy with sequential boost for breast cancer - A preliminary result.
    Lee HH; Hou MF; Chuang HY; Huang MY; Tsuei LP; Chen FM; Ou-Yang F; Huang CJ
    Breast; 2015 Oct; 24(5):656-60. PubMed ID: 26371691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancer.
    Cante D; Franco P; Sciacero P; Girelli G; Marra AM; Pasquino M; Russo G; Borca VC; Mondini G; Paino O; Barmasse R; Tofani S; Numico G; La Porta MR; Ricardi U
    Med Oncol; 2013 Jun; 30(2):518. PubMed ID: 23460537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated Radiotherapy With Simultaneous-integrated Boost After Breast-conserving Surgery Compared to Standard Boost-applications Using Helical Tomotherapy With TomoEdge.
    Zwicker F; Hoefel S; Kirchner C; Huber PE; Debus J; Schempp M
    Anticancer Res; 2021 Apr; 41(4):1909-1920. PubMed ID: 33813396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial.
    Forster T; Hommertgen A; Häfner MF; Arians N; König L; Harrabi SB; Schlampp I; Köhler C; Meixner E; Heinrich V; Weidner N; Hüsing J; Sohn C; Heil J; Golatta M; Hof H; Krug D; Debus J; Hörner-Rieber J
    Radiother Oncol; 2021 Oct; 163():165-176. PubMed ID: 34480960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life after accelerated breast irradiation in five fractions: A comparison with fifteen fractions.
    Van Hulle H; Vakaet V; Bultijnck R; Deseyne P; Schoepen M; Van Greveling A; Post G; De Neve W; Monten C; Lievens Y; Veldeman L
    Radiother Oncol; 2020 Oct; 151():47-55. PubMed ID: 32663539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary-related patient-reported outcomes in a randomized clinical trial of radiation therapy for breast cancer.
    Van Parijs H; Vinh-Hung V; Fontaine C; Storme G; Verschraegen C; Nguyen DM; Adriaenssens N; Nguyen NP; Gorobets O; De Ridder M
    BMC Cancer; 2021 Nov; 21(1):1177. PubMed ID: 34736429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.
    Gil GOB; de Andrade WP; Diniz PHC; Cantidio FS; Queiroz IN; Gil MLBV; Almeida CAM; Caldeira PPR; Regalin M; Silva-Filho AL
    Front Oncol; 2023; 13():1202544. PubMed ID: 37388233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypofractionated Breast Radiation: Shorter Scheme, Lower Toxicity.
    Linares I; Tovar MI; Zurita M; Guerrero R; Expósito M; Del Moral R
    Clin Breast Cancer; 2016 Aug; 16(4):262-8. PubMed ID: 26454613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens.
    Jacobs DHM; Charaghvandi RK; Horeweg N; Maduro JH; Speijer G; Roeloffzen EMA; Mast M; Bantema-Joppe E; Petoukhova AL; van den Bongard DHJG; Koper P; Crijns APG; Marijnen CAM; Verkooijen HM
    Breast Cancer Res Treat; 2021 Sep; 189(2):387-398. PubMed ID: 34216316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 years.
    Pinnarò P; Soriani A; Landoni V; Giordano C; Papale M; Marsella A; Marucci L; Arcangeli G; Strigari L
    J Exp Clin Cancer Res; 2010 Jan; 29(1):9. PubMed ID: 20100335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients.
    Jacobs DHM; Speijer G; Petoukhova AL; Roeloffzen EMA; Straver M; Marinelli A; Fisscher U; Zwanenburg AG; Merkus J; Marijnen CAM; Mast ME; Koper PCM
    Breast Cancer Res Treat; 2018 Jun; 169(3):549-559. PubMed ID: 29460031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects.
    Guenzi M; Vagge S; Azinwi NC; D'Alonzo A; Belgioia L; Garelli S; Gusinu M; Corvò R
    Radiat Oncol; 2010 Nov; 5():111. PubMed ID: 21092219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.